The Persistent Uncertainty of When to Recommend Allogeneic Stem Cell Transplantation in Follicular Lymphoma

Cancer - United States
doi 10.1002/cncr.31565
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in the New Drugs Era.

Mediterranean Journal of Hematology and Infectious Diseases
Infectious DiseasesHematology
2016English

Stem Cell Transplantation in Follicular Lymphoma: Progress at Last?

Bone Marrow Transplantation
TransplantationHematology
2004English

Allogeneic Hematopoietic Stem Cell Transplantation

Archives of Internal Medicine
2002English

Brentuximab Vedotin Prior to Allogeneic Stem Cell Transplantation in Hodgkin Lymphoma: A Report From the EBMT Lymphoma Working Party

British Journal of Haematology
Hematology
2018English

Major Clinical Response to Nivolumab in Relapsed/Refractory Hodgkin Lymphoma After Allogeneic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2016English

The Microbiome and Allogeneic Stem Cell Transplantation

Current Stem Cell Reports
GeneticsDevelopmental BiologyCell BiologyMolecular Biology
2015English

Diffuse Large B-Cell Lymphoma of Bones in a Patient After Allogeneic Hematopoietic Stem Cells Transplantation Due to Hodgkin’s Lymphoma

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2014English

Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation in the Rituximab Era

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Post-Transplant Lymphoproliferative Disorder in Patients With Lymphoma After Allogeneic Hematopoietic Stem Cell Transplantation

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy